A detailed history of Avantax Advisory Services, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 5,701 shares of BIO stock, worth $1.79 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,701
Previous 5,705 0.07%
Holding current value
$1.79 Million
Previous $1.56 Million 22.4%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$263.97 - $344.64 $1,055 - $1,378
-4 Reduced 0.07%
5,701 $1.91 Million
Q2 2024

Aug 09, 2024

BUY
$268.26 - $339.48 $1.53 Million - $1.94 Million
5,705 New
5,705 $1.56 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.71B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.